# OnCo record artios-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/artios-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "artios-pharma" ;
  schema:name "Artios Pharma"@en ;
  schema:alternateName "Artios Pharma Ltd"@en, "Artios Pharma Limited"@en, "Artios"@en ;
  schema:description "Artios Pharma is a Cambridge, UK biotechnology company that leads two cancer trials in OnCo, testing its DNA damage response inhibitors ART0380 (ATR) and ART6043 (DNA polymerase theta) in advanced solid tumours."@en ;
  schema:url <https://onco.cc/companies/artios-pharma/>, <https://www.artios.com> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.artios.com>, <https://www.wikidata.org/wiki/Q140045444>, <https://clinicaltrials.gov/search?lead=Artios%20Pharma%20Ltd> ;
  onco:tag "ctgov-sponsor", "wave5-sponsor" ;
  schema:addressCountry "GB" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:targets <https://onco.cc/targets/atr/> ;
  onco:pathways <https://onco.cc/pathways/ddr/> ;
  onco:trials <https://onco.cc/trials/nct04657068/>, <https://onco.cc/trials/nct05898399/> .